The Charlotte Lozier Institute (CLI) has added five experts in science and bioethics to the ranks of its associate scholars’ team.
“Richard Doerflinger, Maria Feeney, Katherine Rafferty, Tara Sander Lee, and Kathleen Schmainda have already made significant contributions to building a culture of life through their research, writing, and speaking. Charlotte Lozier Institute is honored to welcome these respected, highly accomplished experts to our list of scholars covering the most pressing life-related issues of the day,” said Chuck Donovan, president of Charlotte Lozier Institute.
Will induced pluripotent stem cells (iPSCs) finally replace human embryonic stem cells (hESCs) in the field of regenerative medical research?
Results of a recent study published in Nature Biotechnology argue that they should.
First, some background.
In 2007, Japanese scientist Shinya Yamanaka discovered a method to create fully pluripotent, embryonic-like stem cells from ordinary somatic (body) cells. The ability to do this had been characterized as the “holy grail” of stem cell research and, indeed, Yamanaka’s achievement changed the field of regenerative medicine. So groundbreaking was his discovery that he was awarded the Nobel Prize just five years after announcing it.
The National Catholic Bioethics Quarterly is an invaluable resource not only for insights on ethical issues but news about key developments in medicine and technology. This summer NCBQ added a new author to its array of resources, a regular update on Science written by Charlotte Lozier Institute Vice President and Director of Research, David Prentice, Ph.D.